← All companies

Vor Bio

Healthcare & Life Sci

Company overview

Vor Bio develops therapies for autoimmune diseases, aiming to correct the underlying biology rather than just control symptoms. Its lead product, telitacicept, is a first-in-class BAFF/APRIL inhibitor designed to rebalance immunity and deliver consistent clinical benefit.

Telitacicept has 5 approvals in China across multiple autoimmune conditions, treating tens of thousands of patients there commercially. Jean-Paul Kress, MD serves as Chief Executive Officer and Chairman.

Industry
Healthcare & Life Sci
Headquarters
Boston, United States

Filters

Create your account

Create an account to save jobs and track applications.